The role of the vascular dendritic cell network in atherosclerosis

Noah Alberts-Grill1, Timothy L Denning, Amir Rezvan

  • 1Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA.

Insights

Dendritic cells (DCs) play a dual role in vascular inflammation and atherosclerosis. Understanding their subsets and functions is key to developing DC-based therapies for atherosclerosis.

Area of Science:

  • Immunology
  • Vascular Biology
  • Atherosclerosis Research

Background:

  • Dendritic cells (DCs) are implicated in vascular inflammation and atherosclerosis.
  • Resident vascular DCs reside in atherosclerosis-prone areas with disturbed blood flow.
  • Distinct vascular DC subsets exhibit functional heterogeneity impacting vascular homeostasis.

Purpose of the Study:

  • To review the literature on vascular DC subsets, their origin, and function.
  • To discuss the disruption of DC homeostasis during atherogenesis.
  • To evaluate DC-based "atherosclerosis vaccine" therapies and differentiate DCs from macrophages.

Main Methods:

  • Literature review of existing studies on vascular dendritic cells.
  • Characterization of phenotypically and functionally distinct vascular DC subsets.
  • Analysis of DC roles in immune activation, tolerance, and atherogenesis.

Main Results:

  • Vascular DCs contribute to immune balance in healthy vasculature.
  • Disrupted DC functions during atherogenesis promote atherosclerosis.
  • DC-based therapies show potential for atherosclerosis treatment.

Conclusions:

  • Vascular DCs are critical regulators of vascular health and disease.
  • Further research is needed to distinguish DCs from macrophages and explore therapeutic strategies.
  • Understanding DC heterogeneity is vital for advancing atherosclerosis treatment.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Inflammation01:38

Inflammation

Overview
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...